Multiple endocrine neoplasia type 1 deletion in pancreatic α-cells leads to development of insulinomas in mice

Endocrinology

Volumn 151, Issue 8, 2010, Pages 4024-4030

  Shen, H C Jennifer ^a   Ylaya, Kris ^a   Pechhold, Klaus ^b   Wilson, Arianne ^a   Adem, Asha ^c   Hewitt, Stephen M ^a   Libutti, Steven K ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GLUCOSE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DELETION; GENE TARGETING; GENETIC ANALYSIS; GLUCAGONOMA; HISTOPATHOLOGY; INSULINOMA; MEN1 TUMOR SUPPRESSOR GENE; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; CELLS, CULTURED; GENE DELETION; GENE KNOCKDOWN TECHNIQUES; GLUCAGON; GLUCAGON-SECRETING CELLS; INSULINOMA; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS;

EID: 77954946954     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1251     Document Type: Article

References (26)

1. Gromada J, Franklin I, Wollheim CB 2007 α-Cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28:84-116 (Pubitemid 46220851)
2. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A 2006 The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA 103:2334-2339 (Pubitemid 43271670)
3. Bonner-Weir S, Orci L 1982 New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31:883-889 (Pubitemid 12013792)
4. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-407
5. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G, Pugeat M, Calender A, Parente F, Quincey D, Gaudray P, De Wit MJ, Lips CJ, Höppener JW, Khodaei S, Grant AL, Weber G, Kytölä S, Teh BT, Farnebo F, Thakker RV 1997 Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European consortium on MEN1. Hum Mol Genet 6:1177-1183 (Pubitemid 27308405)
6. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA 1998 Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129:484-494 (Pubitemid 28428085)
7. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, O'Halloran D, Sampson J, Shalet SM, Wheeler MH, Zink A, Thakker RV 1996 Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 89:653-669
8. Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX, Wang ZQ 2003 Pancreatic β-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res 63:4836-4841 (Pubitemid 37022614)
9. Biondi CA, Gartside MG, Waring P, Loffler KA, Stark MS, Magnuson MA, Kay GF, Hayward NK 2004 Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Mol Cell Biol 24:3125-3131
10. Crabtree JS, Scacheri PC, Ward JM, McNally SR, Swain GP, Montagna C, Hager JH, Hanahan D, Edlund H, Magnuson MA, Garrett-Beal L, Burns AL, Ried T, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS 2003 Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol 23:6075-6085
11. Libutti SK, Crabtree JS, Lorang D, Burns AL, Mazzanti C, Hewitt SM, O'Connor S, Ward JM, Emmert-Buck MR, Remaley A, Miller M, Turner E, Alexander HR, Arnold A, Marx SJ, Collins FS, Spiegel AM 2003 Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Res 63:8022-8028
12. Shen HC, Adem A, Ylaya K, Wilson A, He M, Lorang D, Hewitt SM, Pechhold K, Harlan DM, Lubensky IA, Schmidt LS, Linehan WM, Libutti SK 2009 Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations. PLoS One 4:e4897
13. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, Nagy A 1999 Z/AP, a double reporter for cre-mediated recombination. Dev Biol 208:281-292 (Pubitemid 29183990)
14. Shen HC, He M, Powell A, Adem A, Lorang D, Heller C, Grover AC, Ylaya K, Hewitt SM, Marx SJ, Spiegel AM, Libutti SK 2009 Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. Cancer Res 69:1858-1866
15. Pechhold K, Zhu X, Harrison VS, Lee J, Chakrabarty S, Koczwara K, Gavrilova O, Harlan DM 2009 Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes. Diabetes 58:1175-1184
16. Bergman L, Boothroyd C, Palmer J, Grimmond S, Walters M, Teh B, Shepherd J, Hartley L, Hayward N 2000 Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours. Br J Cancer 83:1003-1008
17. Ma W, Tessarollo L, Hong SB, Baba M, Southon E, Back TC, Spence S, Lobe CG, Sharma N, Maher GW, Pack S, Vortmeyer AO, Guo C, Zbar B, Schmidt LS 2003 Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Cancer Res 63:5320-5328
18. Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS 2001 A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98:1118-1123
19. Bertolino P, Tong WM, Galendo D, Wang ZQ, Zhang CX 2003 Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol Endocrinol 17:1880-1892 (Pubitemid 37072302)
20. Loffler KA, Biondi CA, Gartside M, Waring P, Stark M, Serewko-Auret MM, Muller HK, Hayward NK, Kay GF 2007 Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. Int J Cancer 120:259-267 (Pubitemid 44956834)
21. Pechhold S, Stouffer M, Walker G, Martel R, Seligmann B, Hang Y, Stein R, Harlan DM, Pechhold K 2009 Transcriptional analysis of intracytoplasmically stained, FACS-purified cells by high-throughput, quantitative nuclease protection. Nat Biotechnol 27:1038-1042
22. Lu J, Herrera PL, Carreira C, Bonnavion R, Seigne C, Calender A, Bertolino P, Zhang CX 2010 α-Cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. Gastroenterology 138:1954-1965
23. Herrera PL 2000 Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 127:2317-2322
24. Herrera PL, Nepote V, Delacour A 2002 Pancreatic cell lineage analyses in mice. Endocrine 19:267-278
25. Doetschman T 2009 Influence of genetic background on genetically engineered mouse phenotypes. Methods Mol Biol 530:423-433
26. Yoshiki A, Moriwaki K 2006 Mouse phenome research: implications of genetic background. ILAR J 47:94-102